Importantly, this axis protects mice against the development of overt inflammation in models of sepsis, viral infection, and psoriasis, demonstrating a generalized mechanism, and suggesting that promoting the activin A/Smad3 pathway could provide a therapeutic strategy in these diseases. This evidence concerns the gene SMAD3 and viral infectious disease.